475 results on '"Reveille J"'
Search Results
2. POS0501 GENDER AND AGE-OF-ONSET ARE ASSOCIATED WITH RADIOGRAPHIC PROGRESSION IN AXIAL SPONDYLOARTHRITIS
3. Efficacy and Safety of Epratuzumab in Moderately to Severely Active Systemic Lupus Erythematosus: Results From Two Phase III Randomized, Double‐Blind, Placebo‐Controlled Trials
4. OP0154 COMORBIDITY CLUSTERS IN ANKYLOSING SPONDYLITIS AND THEIR ASSOCIATION WITH DISEASE ACTIVITY AND FUNCTIONAL IMPAIRMENT: DATA FROM THE PSOAS COHORT
5. OP0034 IXEKIZUMAB IMPROVES SIGNS, SYMPTOMS, AND QUALITY OF LIFE IN PATIENTS WITH AXIAL SpA IRRESPECTIVE OF DISEASE DURATION: RESULTS FROM THE COAST-V, COAST-W AND COAST-X TRIALS
6. Association between copy number variations of HLA-DQA1 and ankylosing spondylitis in the Chinese Han population
7. Supplement to: Proteome-wide analysis and CXCL4 as a biomarker in systemic sclerosis
8. Association study of genes related to bone formation and resorption and the extent of radiographic change in ankylosing spondylitis
9. Development of a health index in patients with ankylosing spondylitis (ASAS HI): final result of a global initiative based on the ICF guided by ASAS
10. EVALUATION OF SPINAL RADIOGRAPHIC PROGRESSION IN PATIENTS WITH RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS RECEIVING IXEKIZUMAB THERAPY OVER 2 YEARS
11. A functional haplotype of UBE2L3 confers risk for systemic lupus erythematosus
12. Role of MYH9 and APOL1 in African and non-African populations with lupus nephritis
13. Complement receptor 2 polymorphisms associated with systemic lupus erythematosus modulate alternative splicing
14. Replication of the BANK1 genetic association with systemic lupus erythematosus in a European-derived population
15. Genetic associations of LYN with systemic lupus erythematosus
16. Treating axial and peripheral spondyloarthritis, including psoriatic arthritis, to target: results of a systematic literature search to support an international treat-to-target recommendation in spondyloarthritis
17. Efficacy of certolizumab pegol on signs and symptoms of axial spondyloarthritis including ankylosing spondylitis: 24-week results of a double-blind randomised placebo-controlled Phase 3 study
18. Frequency of the Position 122 (VAL→ILE) Variant Transthyretin Gene in Blacks Without Amyloidosis
19. POS0902 EFFICACY AND SAFETY OF INTRAVENOUS GOLIMUMAB IN ANKYLOSING SPONDYLITIS PATIENTS WITH EARLY VS LATE DISEASE THROUGH WEEK 52 OF GO-ALIVE STUDY
20. POS0918 EVALUATION OF SPINAL RADIOGRAPHIC PROGRESSION IN PATIENTS WITH RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS RECEIVING IXEKIZUMAB THERAPY OVER 2 YEARS
21. POS0904 FACTORS ASSOCIATED WITH SWITCHING FROM ONE ANTI-TNF AGENT TO ANOTHER ANTI-TNF, OR IL17 AGENT IN PATIENT WITH ANKYLOSING SPONDYLITIS
22. POS0909 IXEKIZUMAB IMPROVES SIGNS, SYMPTOMS AND QUALITY OF LIFE OF ANKYLOSING SPONDYLITIS IN PATIENTS IRRESPECTIVE OF HLA-B27 STATUS: POOLED RESULTS FROM THE COAST-V AND COAST-W TRIALS
23. Interferon regulatory factor-5 is genetically associated with systemic lupus erythematosus in African Americans
24. A missense mutation in the MLKL brace region promotes lethal neonatal inflammation and hematopoietic dysfunction
25. S.12.1 Is H1N1 influenza vaccine safe and effective in patients with SSc?
26. S.11.1 Influence of digital ulcer healing on disability and daily activity limitations in SSc
27. S.2.1 Identifying and quantifying prognostic factors in SSc-related interstitial lung disease using a time-varying covariate survival model
28. BANK1 functional variants are associated with susceptibility to diffuse systemic sclerosis in Caucasians
29. MHC class II and non-MHC genes in the pathogenesis of systemic lupus erythematosus
30. Prospective meta-analysis of interleukin 1 gene complex polymorphisms confirms associations with ankylosing spondylitis
31. Predictors of premature gonadal failure in patients with systemic lupus erythematosus. Results from LUMINA, a multiethnic US cohort (LUMINA LVIII)
32. Angiotensin-converting enzyme inhibitors delay the occurrence of renal involvement and are associated with a decreased risk of disease activity in patients with systemic lupus erythematosus—results from LUMINA (LIX): a multiethnic US cohort
33. Seizures in patients with systemic lupus erythematosus: data from LUMINA, a multiethnic cohort (LUMINA LIV)
34. The use of anti-tumour necrosis factor therapy in HIV-positive individuals with rheumatic disease
35. Systemic lupus erythaematosus in a multiethnic US cohort (LUMINA) LIII: disease expression and outcome in acute onset lupus
36. Associated factors and impact of myocarditis in patients with SLE from LUMINA, a multiethnic US cohort
37. Clinical, radiographic and functional differences between juvenile-onset and adult–onset ankylosing spondylitis: results from the PSOAS cohort
38. Systemic lupus erythematosus in a multiethnic US cohort LUMINA LI: Anaemia as a predictor of disease activity and damage accrual
39. Combined analysis of three whole genome linkage scans for Ankylosing Spondylitis
40. Systemic lupus erythematosus in a multiethnic US cohort (LUMINA) XL II: factors predictive of new or worsening proteinuria
41. Systemic lupus erythematosus in a multiethnic US cohort LUMINA (XLI): factors predictive of self-reported work disability
42. Predictors of post-partum damage accrual in systemic lupus erythematosus: data from LUMINA, a multiethnic US cohort (XXXVIII)
43. Systemic lupus erythematosus in a multiethnic cohort: LUMINA XXXV. Predictive factors of high disease activity over time
44. Systemic lupus erythematosus in a multiethnic US cohort (LUMINA): XXIV. Cytotoxic treatment is an additional risk factor for the development of symptomatic osteonecrosis in lupus patients: results of a nested matched case–control study
45. Systemic lupus erythematosus in a multiethnic cohort (LUMINA): XXVIII. Factors predictive of thrombotic events
46. Lack of recording of systemic lupus erythematosus in the death certificates of lupus patients
47. Systemic lupus erythematosus in a multiethnic US Cohort (LUMINA). XXX: association between C-reactive protein (CRP) gene polymorphisms and vascular events
48. HLA class II associations confirm alopecia areata phenotypic subtypes: 640
49. Lack of association of matrix metalloproteinase 3 (MMP3) genotypes with ankylosing spondylitis susceptibility and severity
50. Abnormal galactosylation of serum IgG in patients with systemic lupus erythematosus and members of families with high frequency of autoimmune diseases
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.